Bayer hikes 2026 profit outlook as pharma unit beats expectations
Nov 2, 2026
Bayer raised its 2026 profit forecast following strong pharmaceutical performance, expecting adjusted core earnings of €9.8-10.3 billion and reducing net debt projections by €1 billion.
2026-06-16
Bayer Accelerates Biofuel Feedstock PlanShow all 18 updates